Connect with us

Technology

Manufacturing Industry’s Path to Innovation and Efficiency Lies in Exponential IT, Says Info-Tech Research Group

Published

2 years ago

on

Info-Tech Research Group is offering durable goods manufacturers a strategic guide to adopting an Exponential IT mindset. In a recently published blueprint focused on enhancing operational efficiency, predictive maintenance, and supply chain optimization, the firm outlines actionable strategies for IT leaders in the manufacturing industry to leverage advanced technologies to improve productivity, innovation, and customer engagement.

TORONTO, June 17, 2024 /PRNewswire/ – Facing heightened competition, aging legacy equipment, and significant technical debt, the manufacturing sector is under immense pressure to innovate and modernize its operations, Info-Tech Research Group explains in a new industry resource. The global research and advisory firm highlights in Priorities for Adopting an Exponential IT Mindset in the Durable Goods Manufacturing Industry that manufacturing companies must embrace exponential technologies to improve competitive positioning, with IT leaders playing a key role as valued business partners in this transformation. The new research-backed blueprint provides manufacturing and IT leaders with strategic insights and actionable plans to predict market shifts, enable proactive technology investments, and drive modernization through Exponential IT, ensuring they maintain their competitive edge and avoid disruptions.

“From digitizing service models to computerizing operations and the new influx of artificial intelligence processing, information technology has drastically changed organizations,” says Kevin Tucker, advisory practice lead at Info-Tech Research Group. “To make the most of this impending opportunity, IT executives will need to transform into business leaders who can unlock advanced value and insights for their company while reducing risk by implementing an IT transformation. But in the world of Exponential IT, where new skills and capacities are needed, innovation readiness is often still a mystery.”

Info-Tech defines Exponential IT as the strategic integration of rapidly advancing technologies that can revolutionize the manufacturing sector. These technologies, including automation, artificial intelligence, and advanced analytics, empower manufacturing companies to enhance operational efficiency, improve resource management, and innovate production processes. Embracing an Exponential IT mindset allows manufacturers to tackle digital transformation head-on, ensuring sustainable business growth and maintaining a competitive edge.

“The manufacturing industry is urged to rapidly inject an Exponential IT implementation into its roadmap to address potential industry disruptions,” explains Tucker. “It is essential for businesses to grasp the main priorities of Exponential IT transformation to stay competitive in today’s challenging environment. Recognizing and integrating core foundational capabilities are considered crucial initial steps in starting a successful Exponential IT transformation, resulting in the generation of value in the industry.”

The firm’s research outlines critical challenges faced by the durable goods manufacturing sector in adopting Exponential IT. Key issues include the integration of cutting-edge technologies with legacy systems, the persistent difficulty in attracting and retaining skilled IT professionals, and the urgent need for effective data governance. Many manufacturers also contend with fragmented data management and the dual pressures of innovation and regulatory compliance. Overcoming these challenges demands an approach encompassing strategic planning, targeted investments in upskilling staff, and a culture that embraces technological advancement. By fortifying foundational IT capabilities and enhancing digital proficiency, manufacturers can successfully navigate digital transformation, achieving substantial gains in operational efficiency and improved customer engagement.

Info-Tech’s recently published blueprint emphasizes the strategic use of advanced technologies, such as AI and data analytics, for predictive maintenance, supply chain optimization, and customer experience personalization. This approach not only safeguards sensitive data but also leverages it to fuel innovation and boost overall business performance. The firm advises that by prioritizing these technological advancements, manufacturing organizations can develop more flexible and responsive operations, ensuring sustained success in the dynamic manufacturing landscape.

In the resource, Info-Tech outlines four key priorities that manufacturing IT leaders must consider as they adopt an Exponential IT mindset:

Fund exponential value creation: As the market and IT’s roles evolve, IT budgets will need to shift significantly toward innovation. This includes focusing on efficiency, sustainability, cost reduction, and faster product quality enhancement. More funding should also be directed toward advanced human-machine technologies that improve employee safety.Team up DataOps with ModelOps: Companies are increasingly recognizing that data is their most critical asset. While data has always been important, the rise of AI and machine learning has further elevated its significance. These advanced technologies are essential for rapid decision-making, but poor-quality data can lead to poor decisions. Integrating DataOps with ModelOps ensures data integrity and effective model management.Transform infrastructure and applications into utilities: Shifting towards a utility-based model for infrastructure and applications promotes a collaborative and innovative approach to IT asset management. Leveraging cloud solutions and low-code/no-code platforms gives organizations greater control over their outcomes and agility to respond to market changes.Let AI take over core operations: The growing importance of data, driven by AI and machine learning, is transforming core operations. AI can enhance system efficiency, accelerate incident detection, and boost automation productivity. Ensuring high-quality data is crucial, as poor data can lead to poor decisions. Proper integration of AI in core operations allows for rapid, accurate decision-making and improved overall performance.

As the manufacturing sector navigates the complexities of the digital era, prioritizing these strategies will equip organizations to drive innovation, maintain robust data security, and deliver value-rich, personalized services that meet evolving market demands.

By adopting an Exponential IT mindset, manufacturing companies can effectively address the multifaceted challenges of digital transformation, enhance their technological frameworks, and achieve substantial improvements in operational efficiency and customer engagement. This proactive approach ensures not only operational resilience but also a competitive edge in an increasingly dynamic market.

For exclusive and timely commentary on this topic from Info-Tech’s analysts and access to the complete Priorities for Adopting an Exponential IT Mindset in the Durable Goods Manufacturing Industry blueprint, please contact pr@infotech.com.

Info-Tech LIVE 2024 Conference

Registration is now open for Info-Tech Research Group’s annual IT conference,  Info-Tech LIVE 2024, taking place September 17 to 19, 2024, at the iconic Bellagio in Las Vegas. This premier event will also offer journalists, podcasters, and media influencers access to exclusive content, the latest IT research and trends, and the opportunity to interview industry experts, analysts, and speakers. To apply for media passes to attend the event or to gain access to research and expert insights on trending topics, please contact pr@infotech.com.

About Info-Tech Research Group

Info-Tech Research Group is one of the world’s leading research and advisory firms, proudly serving over 30,000 IT and HR professionals. The company produces unbiased, highly relevant research and provides advisory services to help leaders make strategic, timely, and well-informed decisions. For nearly 30 years, Info-Tech has partnered closely with teams to provide them with everything they need, from actionable tools to analyst guidance, ensuring they deliver measurable results for their organizations.

To learn more about Info-Tech’s divisions, visit McLean & Company for HR research and advisory services and SoftwareReviews for software buying insights.  

Media professionals can register for unrestricted access to research across IT, HR, and software and hundreds of industry analysts through the firm’s Media Insiders program. To gain access, contact pr@infotech.com. 

For information about Info-Tech Research Group or to access the latest research, visit infotech.com and connect via LinkedIn and X.

View original content to download multimedia:https://www.prnewswire.com/news-releases/manufacturing-industrys-path-to-innovation-and-efficiency-lies-in-exponential-it-says-info-tech-research-group-302174523.html

SOURCE Info-Tech Research Group

Related Topics:
Continue Reading

Technology

HiTHIUM Partners with the University of Cambridge to Advance International Industry-Academia Collaboration in Long-Duration Energy Storage

Published

1 hour ago

on

November 14, 2026

By

XIAMEN, China, Nov. 14, 2026 /PRNewswire/ — On November 12, the Global Energy Storage Colloquium was held in Xiamen. During the colloquium, HiTHIUM and the University of Cambridge signed a memorandum of understanding (MoU), establishing a strategic partnership. The two parties will collaborate on frontier scientific research, key technology innovation and industrial applications in battery energy storage, bringing academic research into closer alignment with industry needs and exploring new models for international industry-academia collaboration. The partnership aims to contribute to the advancement of global energy storage technology and the industry.

The UK has a strong track record in the development of modern battery technologies and fundamental research. The University of Cambridge is one of the world’s leading universities, with internationally recognized expertise in engineering, materials science and fundamental research. As a leading global energy storage technology company, HiTHIUM has long focused on energy storage technology development and commercialization. It continues to advance integrated research and innovation across the value chain, from high-capacity energy storage cells to long-duration energy storage systems and grid integration technologies.

The collaboration is intended to bring internationally leading academic research into closer engagement with innovation across China’s energy storage industry. The University of Cambridge’s strengths in fundamental science, materials research and engineering will offer new perspectives and approaches to key scientific questions and emerging technologies in energy storage. HiTHIUM will bring its experience in long-duration energy storage (LDES), product development and large-scale deployment, connecting research with real industry needs and application scenarios, and supporting the engineering validation and commercialization of research outcomes. By drawing on the strengths of both research and industry, the partnership will strengthen the links between frontier innovation and practical applications.

Under the cooperation plan, the two parties will establish joint management and research collaboration mechanisms, bringing together academic resources and corporate R&D capabilities. They will work together to plan research projects, facilitate scientific exchange and support the translation of research outcomes, strengthening connections between fundamental research, technology development and industrial applications so that innovation in energy storage can better serve industry needs.

The partnership also marks an important step in HiTHIUM’s efforts to expand its international innovation network. Building on this collaboration with the University of Cambridge, HiTHIUM will further strengthen academic exchanges and research partnerships with leading universities and research institutions around the world. By bringing together international research resources and talent, the company aims to encourage collaboration across disciplines and technology fields, explore the development of technologies such as LDES from a global perspective, and bring technical challenges and application needs from the front lines of industry into research and innovation. This will help research and industrial practice reinforce one another.

View original content to download multimedia:https://www.prnewswire.com/news-releases/hithium-partners-with-the-university-of-cambridge-to-advance-international-industry-academia-collaboration-in-long-duration-energy-storage-302939492.html

SOURCE HiTHIUM

Continue Reading

Technology

The NYSE Welcomes vVARDIS as a Publicly Listed Company

Published

2 hours ago

on

November 14, 2026

By

NEW YORK, Nov. 14, 2026 /PRNewswire/ — vVARDIS (NYSE: VVVV) co-founders Dr. Haley Abivardi and Dr. Goly Abivardi aim to reshape the future of dental care with a drill-free treatment for the world’s #1 non-communicable disease: cavities.

vVARDIS Solves a Problem that Millions FaceTooth decay affects billions of people worldwide, and dental anxiety keeps millions from getting the care they need.vVARDIS is a Swiss dental technology company focused on changing the way early tooth decay is treated.vVARDIS has introduced a new approach that aims to treat decay earlier and more comfortably for patients.Its flagship product, Curodont® Repair Fluoride Plus, uses proprietary peptide technology to help repair early-stage tooth decay by supporting the natural remineralization of enamel — simply put No drill, No needle, or No filling.Tooth Decay is One of the Most Common Health Issues in the World2.5 billion people globally live with untreated tooth decay.Nearly 90% of U.S. adults have experienced tooth decay.Nearly 73% of U.S. adults report dental fear.21% avoid the dentist because of anxiety.The Story that Helped Shape vVARDISFor decades, treating early tooth decay often meant waiting until it worsened or getting a filling. The founders spent 25 years developing Curodont® Repair Fluoride Plus, a treatment that helps repair early tooth decay before it becomes a cavity.Curodont® gives dentists a way to treat early decay while making the experience easier and less intimidating for patients.The technology has already treated more than 2.5 million teethAvailable in more than 20% of U.S. dental practices

Click Here to Learn More about vVARDIS: https://www.youtube.com/watch?v=T1p9hUR5Glk

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/the-nyse-welcomes-vvardis-as-a-publicly-listed-company-302939487.html

SOURCE New York Stock Exchange

Continue Reading

Technology

Innovative Immunology Biotech Windward Bio Lists on Nasdaq

Published

5 hours ago

on

November 14, 2026

By

SHANGHAI, Nov. 14, 2026 /PRNewswire/ — Windward Bio, a portfolio company of Qiming Venture Partners and a clinical-stage biotechnology company, successfully listed on Nasdaq on November 13, 2026. Windward Bio (Nasdaq: WWB) priced its IPO at $17.00 per share. Its shares closed at $28.50 on the first trading day, up 68% from the IPO price, giving the company a market capitalization of approximately $1.69 billion. This is Qiming Venture Partners’ 11th IPO in 2026.

Qiming Venture Partners invested in Windward Bio’s inaugural Series A financing in 2025 and continued to support the company in its Series B financing in 2026. Qiming also participated in this IPO financing round.

Windward Bio was founded in 2024 with a mission to transform the treatment paradigm for patients living with chronic inflammatory diseases through the development of differentiated biologic therapies targeting clinically validated disease pathways. Led by a team with extensive expertise across discovery, development, and commercialization, Windward Bio is advancing a pipeline of ultra-long-acting antibody medicines to improve clinical outcomes, reduce treatment burden and expand treatment options for patients with serious respiratory and dermatologic diseases, including asthma, chronic obstructive pulmonary disease (COPD) and atopic dermatitis.

Windward Bio’s lead program, WIN378, is a potentially novel anti-TSLP monoclonal antibody engineered for improved potency and extended half-life. WIN378 is currently being evaluated in POLARIS-1, a Phase 2/3 study in severe uncontrolled asthma, and SIRIUS, a Phase 2 study in COPD. The company’s pipeline also includes WIN027, a clinical-stage, long-acting bispecific antibody targeting TSLP and IL-13 with potential applications across multiple inflammatory and immunological diseases. Windward Bio holds exclusive global rights (excluding Greater China and certain Asian countries) to WIN378 through a licensing agreement with Kelun-Biotech and Harbour BioMed, and has separately licensed WIN027 from Qyuns Therapeutics.

“Qiming Venture Partners invests in differentiated, globally competitive biotech innovation designed to address significant unmet needs for patients, and Windward Bio exemplifies this approach. We believe novel, long-acting biologics will reshape the treatment of severe chronic respiratory and skin diseases, and that WIN378 and WIN027 have the potential to expand and meaningfully improve the treatment options available to patients. In the hands of Luca and his team, with their expertise and proven track record, Windward is well-positioned to deliver on this potential, and we look forward to supporting the company through its next phase of growth,” said Alexander Sinclair Wilson, Principal at Qiming Venture Partners.

About Qiming Venture Partners

Qiming Venture Partners was founded in 2006. Currently, Qiming Venture Partners manages eleven US Dollar funds and seven RMB funds with $9.5 billion in capital raised. Since our establishment, we have invested in outstanding companies in the Technology and Healthcare industries at the early and growth stages.

Since our debut, we have backed over 630 fast-growing and innovative companies. Over 290 of our portfolio companies have achieved exits through IPOs at the NYSE, NASDAQ, HKEX, Shanghai Stock Exchange, or Shenzhen Stock Exchange, or through M&A or other means. There are also over 110 portfolio companies that have achieved unicorn or super unicorn status.

Many of our portfolio companies are today’s most influential firms in their respective sectors, including Xiaomi, Meituan, Bilibili, Zhihu, Roborock, Hesai Technology, UBTech, WeRide, HyperStrong, Insta360, Unisound, Biren Technology, Z.AI, Gan & Lee Pharmaceuticals, Tigermed, Zai Lab, CanSino Biologics, Schrödinger, APT Medical, Sanyou Medical, AmoyDx, SinocellTech, Insilico Medicine, AusperBio, Yuanxin Technology, Medilink Therapeutics, LaNova Medicines, StepFun, among many others.

 

View original content:https://www.prnewswire.com/news-releases/innovative-immunology-biotech-windward-bio-lists-on-nasdaq-302939481.html

SOURCE Qiming Venture Partners

Continue Reading

Trending